The modest activity of TMZ against ependymoma cells has been suggested to be due to the lack of O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation [83, 84]; however, even when present, MGMT promoter methylation does not correlate with response to TMZ [80]. The gene discussed is MGMT; the disease is ependymoma.